| | ||||||||||
| 1 | INN | Class | Route (list) | PK parameters= Cmax; Tmax; F: bioavailability; t1/2: half-life; VD: volume of distribution; Cl: clearance; PPB: plasma protein binding;(EQN means that value was calculated using VD=(Cl*t1/2)/0.693) | Primary Target and PDB code of Protein-Drug complex | Targets from DrugCentral | Links | |||
| ALCAFTADINE (has an active metabolite)
| ALCAFTADINE | RESPIRATORY | OPHTHALMIC | Cmax 0.195 PICOMOLAR Tmax 0.25 HOUR PPB 39.2 PERCENT | H1 HISTAMINE RECEPTOR | Histamine H1 receptor UNIPROT P35367 HRH1 more at DrugCentral | EMA | |||
| 2 | INN | Class | Route (list) | PK parameters= Cmax; Tmax; F: bioavailability; t1/2: half-life; VD: volume of distribution; Cl: clearance; PPB: plasma protein binding;(EQN means that value was calculated using VD=(Cl*t1/2)/0.693) | Primary Target and PDB code of Protein-Drug complex | Targets from DrugCentral | Links | |||
| M ALCAFTADINE (is an active metabolite)
| ALCAFTADINE | RESPIRATORY | - | Cmax 9.28 NANOMOLAR Tmax 1 HOUR PPB 62.7 PERCENT HT 2 HOUR | H1 HISTAMINE RECEPTOR | Histamine H1 receptor UNIPROT P35367 HRH1 more at DrugCentral | EMA | |||
